Skip to main content
SpringerLink
Log in

Sacral Neurostimulation: InterStim

  • Chapter
  • First Online:
Minimally Invasive Therapy for Urinary Incontinence and Pelvic Organ Prolapse

Part of the book series: Current Clinical Urology ((CCU))

  • 1310 Accesses

Abstract

Sacral neurostimulation (SNS) is a minimally invasive, reversible treatment option that has been approved by the United States Food and Drug Administration for patients with urgency/frequency and urge incontinence refractory to medical therapy. SNS may work through somatic afferents to modulate bladder and sphincter function. A test stimulation trial using an external neurostimulator can help identify patients who are most likely to respond to the procedure. In this chapter, we examine the indications for SNS and the options for a test stimulation using either temporary or permanent leads. The implantation procedure and previous studies on outcomes after SNS are discussed in addition to cost considerations.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Abrams P, Cardozo L, Fall M, et al. The standardization of terminology of lower tract function: report from the Standardization Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21:167–78.

    Article  PubMed  Google Scholar 

  2. Basra RK, Wagg A, Chapple C, et al. A review of adherence to drug therapy in patients with overactive bladder. BJU Int. 2008;102:774–7.

    Article  PubMed  Google Scholar 

  3. Yoshimura N, Seki S, Chancellor MB, de Groat WC, Ueda T. Targeting afferent hyperexcitability for therapy of the painful bladder syndrome. Urology. 2002;59(5 Supp1):61–7.

    Article  PubMed  Google Scholar 

  4. Fowler CJ, Swinn MJ, Goodwin RJ, Oliver S, Craggs M. Studies of the latency of pelvic floor contraction during peripheral nerve stimulation show that the muscle is reflexly mediated. J Urol. 2000;163:881–3.

    Article  CAS  PubMed  Google Scholar 

  5. Oerlemans DJ, van Kerrebroeck PE. Sacral nerve stimulation for neuromodulation of the lower urinary tract. Neurourol Urodyn. 2008;27:28–33.

    Article  PubMed  Google Scholar 

  6. Brazzelli M, Murray A, Fraser C. Efficacy and safety of sacral nerve stimulation for urinary urge incontinence: a systematic review. J Urol. 2006;175:835–41.

    Article  PubMed  Google Scholar 

  7. Fall M, Lindstrom S. Electrical stimulation. A physiologic approach to the treatment of urinary incontinence. Urol Clin North Am. 1991;18:393–407.

    CAS  PubMed  Google Scholar 

  8. Malaguti S, Spinelli M, Lazzeri M, Giardiello G. Evaluation of afferent pathway modulation in patients implanted with sacral neuromodulation for lower urinary tract symptoms (LUTS). Eu Urol. 2003;1 Suppl 2:143.

    Article  Google Scholar 

  9. van der Pal F, Heesakkers JPFA, Bemelmans BLH. Current opinion on the working mechanisms of neuromodulation in the treatment of lower urinary tract dysfunction. Curr Opin Urol. 2006;16:261–7.

    Article  PubMed  Google Scholar 

  10. Schmidt RA, Jonas U, Oleson KA, et al. Sacral nerve stimulation for the treatment of refractory urinary urge incontinence. Sacral Nerve Stimulation Study Group. J Urol. 1999;162:352–7.

    Article  CAS  PubMed  Google Scholar 

  11. Bazeed MA, Thuroff JW, Schmidt RA, et al. Effect of chronic electrostimulation of the sacral roots on the striated urethral sphincter. J Urol. 1982;128:1357–62.

    CAS  PubMed  Google Scholar 

  12. Abrams P, Andersson KE, Birder I, Brubaker I, Cardozo I, Chapple C, et al. 4th International Consultation on Incontinence: recommendations of the International Scientific Committee: evaluation and treatment of urinary incontinence, pelvic organ prolapse and fecal incontinence. Neurourol Urodyn. 2009;29(1):213–40.

    Article  Google Scholar 

  13. Sievert KD, Amend B, Gakis G, et al. Early sacral neuromodulation prevents urinary incontinence after complete spinal cord injury. Ann Neurol. 2010;67:74–84.

    Article  PubMed  Google Scholar 

  14. Zabihi N, Mourtzinos A, Maher MG, et al. Short-term results of bilateral S2-S4 sacral neuromodulation for the treatment of refractory interstitial cystitis, painful bladder syndrome, and chronic pelvic pain. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19:553–7.

    Article  PubMed  Google Scholar 

  15. Comiter CV. Sacral neuromodulation for the symptomatic treatment of refractory interstitial cystitis: a prospective study. J Urol. 2003;169:1369–73.

    Article  PubMed  Google Scholar 

  16. Powell CR, Kreder KJ. Long-term outcomes of urgency-frequency syndrome due to painful bladder syndrome treated with sacral neuromodulation and analysis of failures. J Urol. 2010;183:173–6.

    Article  PubMed  Google Scholar 

  17. Weil EH, Ruiz-Cerdá JL, Eerdmans PH, et al. Clinical results of sacral neuromodulation for chronic voiding dysfunction using unilateral sacral foramen electrodes. World J Urol. 1998;16:313–21.

    Article  CAS  PubMed  Google Scholar 

  18. Das AK, Carlson AM, Hull M; U.S. MDT-103 Study Group. Improvement in depression and health-related quality of life after sacral nerve stimulation therapy for treatment of voiding dysfunction. Urology. 2004;64:62–8.

    Google Scholar 

  19. Marcelissen TA, Leong RK, Serroyen J, van Kerrekroeck PE, De Wachter SG. The use of bilateral sacral nerve stimulation in patients with loss of unilateral treatment efficacy. J Urol. 2011;185(3):976–80.

    Article  PubMed  Google Scholar 

  20. Cohen BL, Tunuguntla HS, Gousse A. Predictors of success for first stage neuromodulation: motor versus sensory response. J Urol. 2006;175:2178–81.

    Article  PubMed  Google Scholar 

  21. Peters KM, Killinger KA, Boura JA. Is sensory testing during lead placement crucial for achieving positive outcomes after sacral neuromodulation? Neurourol Urodyn. 2011;30(8):1489–92.

    Article  PubMed  Google Scholar 

  22. Siegel SW, Catanzaro F, Dijkema HE, et al. Long-term results of a multicenter study on sacral nerve stimulation for treatment of urinary urge incontinence, urgency-frequency, and retention. Urology. 2000;56(6 Suppl 1):87–91.

    Article  CAS  PubMed  Google Scholar 

  23. Koldewijn EL, Rosier PF, Meuleman EJ, et al. Predictors of success with neuromodulation in lower urinary tract dysfunction: results of trial stimulation in 100 patients. J Urol. 1994;152:2071–5.

    CAS  PubMed  Google Scholar 

  24. Everaert K, Kerckhaert W, Caluwaerts H, et al. A prospective randomized trial comparing the 1-stage with the 2-stage implantation of a pulse generator in patients with pelvic floor dysfunction selected for sacral nerve stimulation. Eur Urol. 2004;45:649–54.

    Google Scholar 

  25. Van Voskuilen AC, Oerlemans DJ, Weil EH, et al. Medium-term experience of sacral neuromodulation by tined lead implantation. BJU Int. 2007;99:107–10.

    Article  PubMed  Google Scholar 

  26. Kessler TM, Madersbacher H, Kiss G. Prolonged sacral neuromodulation testing using permanent leads: a more reliable patient selection method. Eur Urol. 2005;47:660–5.

    Article  PubMed  Google Scholar 

  27. Hijaz A, Vasavada S. Complications and troubleshooting of sacral neuromodulation therapy. Urol Clin North Am. 2005;32:65–9.

    Article  PubMed  Google Scholar 

  28. Leong RK, DeWachter SG, Nieman FH, deBie RA, van Kerrebroeck PE. PNE versus 1st stage tined lead procedure: a direct comparison to select the most sensitive test method to identify patients suitable for sacral neuromodulation therapy. Neurourol Urodyn. 2011;30(7):1249–52.

    PubMed  Google Scholar 

  29. Huwyler M, Kiss G, Burkhard FC, Madersbacher H, Kessler TM. Microbiological tined-lead examination: does prolonged sacral neuromodulation testing induce infection? BJU Int. 2009;104:646–50.

    Article  PubMed  Google Scholar 

  30. Kessler TM, Burkhard FC, Madersbacher H, Kofler A, Poewe W, Kiss G. Safety of prolonged sacral neuromodulation tined lead testing. Curr Med Res Opin. 2008;24(2):343–7.

    Article  PubMed  Google Scholar 

  31. Spinelli M, Sievert K-D. Latest technologic and surgical developments in using InterStim Therapy for sacral neuromodulation: impact on treatment success and safety. Eur Urol. 2008;54:1287–96.

    Article  PubMed  Google Scholar 

  32. Siegel SW. Management of voiding dysfunction with an implantable neuroprosthesis. Urol Clin North Am. 1992;19:163–70.

    CAS  PubMed  Google Scholar 

  33. Scheepens WA, de Bie RA, Weil EH, van Kerrebroeck PE. Unilateral versus bilateral sacral neuromodulation in patients with chronic voiding dysfunction. J Urol. 2002;168(5):2046–50.

    Article  CAS  PubMed  Google Scholar 

  34. Kauffman S, Naumann CM, Mamann MF, Seif C, Braun PM, Junemann KP, et al. Unilateral vs bilateral sacral neuromodulation in pigs with formalin-induced detrusor hyperactivity. BJU Int. 2009;103:230–63.

    Google Scholar 

  35. Thon WF, Baskin LS, Jonas U, et al. Neuromodulation of voiding dysfunction and pelvic pain. World J Urol. 1991;9:138.

    Google Scholar 

  36. Koga L, Furue H, Rashid MH, et al. Selective activation of primary afferent fibers evaluated by since-wave electrical stimulation. Mol Pain. 2005;1:13.

    Article  PubMed Central  PubMed  Google Scholar 

  37. Wantanabe JH, Campbell JD, Ravelo A, et al. Cost analysis of intervention of antimuscarinic refractory patients with overactive bladder. Urology. 2010;76(4):835–40.

    Article  Google Scholar 

  38. Leong RK, de Wachter SG, Joore MA, der Kerrebroeck PE. Cost-effectiveness analysis of sacral neuromodulation and botulinum toxin A treatment for patients with idiopathic overactive bladder. BJU Int. 2011;108(4):558–64.

    Article  CAS  PubMed  Google Scholar 

  39. Siddiqui NY, Amundsen CL, Visco AG, Myers ER, Wu JM. Cost-effectiveness of sacral neuromodulation versus intravesical botulinum A toxin for treatment of refractory urge incontinence. J Urol. 2009;162(6):2799–804.

    Article  Google Scholar 

  40. van Kerrebroeck PE, van Voskuilen AC, Heesakkers JP, et al. Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. J Urol. 2007;178:2029–34.

    Article  PubMed  Google Scholar 

  41. Weil EH, Ruiz-Cerda JL, Eerdmans PH, Janknegt RA, Bemelmans BL, van Kerrebroek PE. Sacral root neuromodulation in the treatment of refractory urinary urge incontinence: a prospective randomized controlled clinical trial. Eur Urol. 2000;37(2):161.

    Article  CAS  PubMed  Google Scholar 

  42. Hassouna MM, Siegel SW, Lycklama A, Nyeholt AAB, Elhilali MM, van Kerrebroeck PEV, Das AK, Gajewski JB, Janknegt RA, Rivas DA, Dijkema H, Milam DF, Oleson KA, Schmidt RA. Sacral neuromodulation in the treatment of urgency frequency symptoms: a multicenter study of efficacy and safety. J Urol. 2000;163:1849–54.

    Article  CAS  PubMed  Google Scholar 

  43. Amundsen CL, Romero AA, Jamison MG, Webser GD. Sacral neuromodulation for intractable urge incontinence: are there factors associated with cure? Urology. 2005;66(4):746.

    Article  PubMed  Google Scholar 

  44. Antolak Jr SJ, Antolak CM. Failed sacral neuromodulation: simple tests demonstrate pudendal neuropathy. A case series. J Pelvic Med Surg. 2006;12:3.

    Article  Google Scholar 

Download references

Disclosure

Dr. Anurag Das has received compensation for teaching courses, proctoring, and developing teaching materials for Medtronic, Inc.

Author information

Authors and Affiliations

  1. Division of Urology, Department of Surgery, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Rabb 440, Boston, MA, 02115, USA

    Ravi Kacker M.D.

  2. Department of Urology, Center for Neuro-urology and Continence, Beth Israel Deaconess Medical Center, Boston, MA, USA

    Anurag K. Das M.D., F.A.C.S.

Authors
  1. Ravi Kacker M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anurag K. Das M.D., F.A.C.S.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ravi Kacker M.D. .

Editor information

Editors and Affiliations

  1. Department of Urology, Wake Forest University, Winston-Salem, North Carolina, USA

    Gopal H. Badlani

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Kacker, R., Das, A.K. (2014). Sacral Neurostimulation: InterStim. In: Badlani, G. (eds) Minimally Invasive Therapy for Urinary Incontinence and Pelvic Organ Prolapse. Current Clinical Urology. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-0008-4_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-0008-4_13

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-0007-7

  • Online ISBN: 978-1-4939-0008-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation